Breaking News1 year ago
Ardelyx wins long battle for FDA approval of kidney-disease treatment
[ad_1] Ardelyx Inc. ARDX, -0.58% on Tuesday won its long fight for U.S. regulatory approval of a treatment designed to help patients with chronic kidney disease....
